Bridging to Paediatric Dosing: Relative Bioavailability of Suspended Rifapentine and Isoniazid in an Open-Label Randomized Trial in Adults on Tuberculosis Preventive Therapy
Clin Pharmacokinet. 2025 Oct 11. doi: 10.1007/s40262-025-01576-3. Online ahead of print. ABSTRACT BACKGROUND AND OBJECTIVES: The use of the 12-dose, once-weekly, rifapentine-based (3HP), short-course tuberculosis …